vancomycin has been researched along with lactulose in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hayashi, K; Ikeda, T; Ito, T; Karube, H; Mizuno, T; Nomoto, T; Okada, T; Sakurai, A; Shindo, K; Tarao, K | 1 |
| Hayashi, K; Ikeda, T; Sakurai, A; Tarao, K | 1 |
| Hayashi, K; Ikeda, T; Ito, T; Okada, T; Sakurai, A; Tarao, K; Tsuchiya, T | 1 |
| Imai, F; Kameda, H | 1 |
| Bickett-Burkhart, K; Chalasani, N; Fischer, M; Gandhi, D; Orman, ES; Phatharacharukul, P; Purpura, RD; Xu, H | 1 |
1 review(s) available for vancomycin and lactulose
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for vancomycin and lactulose
| Article | Year |
|---|---|
Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.
Topics: Ammonia; Bacteria; Disaccharides; Double-Blind Method; Drug Resistance; Electroencephalography; Feces; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Randomized Controlled Trials as Topic; Vancomycin | 1990 |
6 other study(ies) available for vancomycin and lactulose
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Successful use of vancomycin hydrochloride in the treatment of lactulose-resistant chronic hepatic encephalopathy.
Topics: Drug Resistance; Feces; Hepatic Encephalopathy; Humans; Lactulose; Vancomycin | 1989 |
[Therapeutic effect of vancomycin hydrochloride, a nonabsorbable antibiotic, on intractable (lactulose resistant) chronic hepatic encephalopathy in cirrhotic patients].
Topics: Aged; Chronic Disease; Drug Resistance; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Vancomycin | 1986 |
[Liver diseases and colonic dysfunction].
Topics: Colon; Colonic Diseases; Female; Humans; Lactulose; Liver Circulation; Liver Diseases; Middle Aged; Regional Blood Flow; Vancomycin | 1988 |
Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis.
Topics: Aged; Anti-Bacterial Agents; Clostridioides; Clostridium Infections; Comorbidity; Diagnostic Errors; Female; Fidaxomicin; Humans; Incidence; Lactulose; Laxatives; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Failure; Vancomycin | 2020 |